NCCN Oncology Policy Summits
The Impact of Technology on Cancer Care in 2021
September 9, 2021 | 12:00 – 4:00 pm EDTThis FREE online program will explore the rapid advancement of technology and its impact on cancer care. Convening a group of diverse speakers and panelists, the virtual summit will explore how innovation impacts patient outcomes, best practices for the use of technology within care delivery, and policies that influence and support technological advancements and access to high-quality care.
Supporters
Supported by Adaptive; ADC Therapeutics; Apobiologix; AstraZeneca; BeiGene, Ltd.; bluebird bio; BMS; Eisai Inc; EMD Serono; EQRx; Exelixis; Foundation Medicine, Inc.; Genentech; GSK; Helsinn; Heron; Incyte Corporation; Janssen Oncology; Lilly; MorphoSys US, Inc.; QED Therapeutics; Sanofi; Sun Pharma Oncology; and TG Therapeutics.
Upcoming event: Save the date!
- Tuesday, December 7, 2021 – NCCN Patient Advocacy Summit: Advancements in Precision Medicine and Implications for Quality, Accessible, and Equitable Cancer Care
Previous Policy Summits
2021 series
- Defining the "New Normal"— 2021 and the State of Cancer Care in America Following 2020: View video | Article coming soon
2020 series
- Cancer Across the Lifespan: View video | NCCN Digital Resource Booklet | Article coming soon
- Innovative Solutions to Drive Down Healthcare Costs: Implications for Access to High-Quality Cancer Care: Article coming soon
- Accelerating Advances in Cancer Care Research: A Lookback at the 21st Century Cures Act in 2020: View video | View article
2019 series
- Delivering Value for Patients across the Oncology Ecosystem: View article
- Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care: View article
- The State of Cancer Care in America: The Impact of State Policy on Access to High-Quality Cancer Care: View article